Last checked at 8 Oct 2020 07:34
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 05 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
390,464 | 0.17% | 2,558,451 | 1.10% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
538,686 | 0.23% | 28,200 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 106,599 | 0.05% | 106,599 | 0.05% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,035,749 | 0.45% | 2,693,250 | 1.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 34 | 206.5747 USD |
Purchase | 50 | 206.7900 USD |
Purchase | 98 | 206.7884 USD |
Purchase | 147 | 205.8700 USD |
Purchase | 199 | 206.1647 USD |
Purchase | 200 | 205.7300 USD |
Purchase | 200 | 205.9700 USD |
Purchase | 203 | 206.5879 USD |
Purchase | 221 | 205.9609 USD |
Purchase | 365 | 205.9600 USD |
Purchase | 636 | 206.0614 USD |
Purchase | 738 | 206.7861 USD |
Purchase | 936 | 206.3805 USD |
Purchase | 5,389 | 206.2745 USD |
Purchase | 6,127 | 206.3361 USD |
Purchase | 6,532 | 206.5451 USD |
Purchase | 7,289 | 206.1551 USD |
Purchase | 8,128 | 206.5100 USD |
Purchase | 9,417 | 206.6021 USD |
Purchase | 18,540 | 206.0370 USD |
Purchase | 19,126 | 206.4378 USD |
Purchase | 74,888 | 206.1815 USD |
Sale | 3 | 206.5066 USD |
Sale | 4 | 207.0500 USD |
Sale | 34 | 206.5747 USD |
Sale | 42 | 206.5188 USD |
Sale | 50 | 206.7900 USD |
Sale | 98 | 206.7883 USD |
Sale | 100 | 206.0200 USD |
Sale | 100 | 206.2700 USD |
Sale | 100 | 206.6100 USD |
Sale | 100 | 207.1500 USD |
Sale | 100 | 207.5600 USD |
Sale | 156 | 206.2753 USD |
Sale | 199 | 207.0229 USD |
Sale | 250 | 206.4000 USD |
Sale | 291 | 206.0734 USD |
Sale | 310 | 206.4870 USD |
Sale | 380 | 205.2210 USD |
Sale | 456 | 206.1278 USD |
Sale | 938 | 206.3908 USD |
Sale | 1,200 | 205.8077 USD |
Sale | 1,334 | 206.2863 USD |
Sale | 1,767 | 206.0793 USD |
Sale | 1,793 | 206.1890 USD |
Sale | 2,169 | 205.6458 USD |
Sale | 2,207 | 206.1532 USD |
Sale | 2,420 | 206.2567 USD |
Sale | 2,524 | 206.5019 USD |
Sale | 2,599 | 205.9199 USD |
Sale | 3,197 | 205.7410 USD |
Sale | 4,338 | 206.0023 USD |
Sale | 4,528 | 206.4916 USD |
Sale | 4,769 | 206.6104 USD |
Sale | 5,189 | 206.3262 USD |
Sale | 5,213 | 205.8095 USD |
Sale | 5,685 | 206.2132 USD |
Sale | 7,208 | 206.2603 USD |
Sale | 7,556 | 206.5750 USD |
Sale | 8,340 | 206.2417 USD |
Sale | 9,307 | 206.4927 USD |
Sale | 9,364 | 206.5100 USD |
Sale | 10,377 | 206.2391 USD |
Sale | 16,328 | 206.2175 USD |
Sale | 18,346 | 206.2756 USD |
Sale | 18,540 | 206.0370 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 8 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -106,599 | 214.5780 | European | Oct 20, 2020 |
Put Options | Written | 106,599 | 214.5780 | European | Oct 20, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201007006075/en/
Copyright Business Wire 2020